Nanoscale biochemical sample preparation and analysis

Patent metadata

Field	Value
Publication number	US-11123732-B2
Application number	US-201815897022-A
Country	US
Kind code	B2
Filing date	Feb 14, 2018
Priority date	Nov 7, 2016
Publication date	Sep 21, 2021
Grant date	Sep 21, 2021

Abstract

Provided herein are methods and systems for biochemical analysis, including compositions and methods for processing and analysis of small cell populations and biological samples (e.g., a robotically controlled chip-based nanodroplet platform). In particular aspects, the methods described herein can reduce total processing volumes from conventional volumes to nanoliter volumes within a single reactor vessel (e.g., within a single droplet reactor) while minimizing losses, such as due to sample evaporation.

First claim

What is claimed is:

1. A method for preparing a biological sample, comprising the steps of:
obtaining a biological sample by laser-capture microdissection of a biological tissue,
introducing a capture liquid into or onto at least one single reactor vessel, wherein the at least one single reactor vessel is located on a platform including the at least one single reactor vessel having one or more hydrophilic surfaces configured for containment of the biological sample, wherein the hydrophilic surfaces have a non-zero, total surface area less than 1 mm 2 ; wherein the capture liquid has a vapor pressure of less than or equal to 0.8 mbar at room temperature;
transferring a first volume of the biological sample to the at least one single reactor vessel that includes the capture liquid, wherein the first volume is a non-zero amount less than 100 nL;
fully evaporating, or only partially evaporating, the capture liquid after transferring the first volume of the biological sample to the at least one single reactor vessel;
processing the biological sample in the at least one single reactor vessel to yield a processed sample, and
collecting a second volume of the processed sample.

2. The method of claim 1 , wherein the second volume is a fraction of the first volume ranging from about 10 to about 100%.

3. The method of claim 1 , wherein the platform comprises at least two reactor vessels, wherein the at least two reactor vessels are separated by a hydrophobic surface.

4. The method of claim 1 , wherein the biological sample comprises a non-zero amount of cells less than 5000 cells.

5. The method of claim 1 , wherein the biological sample comprises a non-zero amount of cells less than 100 cells.

6. The method of claim 1 , wherein the biological sample comprises a non-zero amount of cells less than 10 cells.

7. The method of claim 1 , further comprising analyzing the collected second volume of the processed biological sample, wherein the analyzing step is configured to identify at least one unique species within the processed biological sample.

8. The method of claim 7 , wherein the analyzing step identifies at least 1,000 unique species.

9. The method of claim 7 , wherein the analyzing step identifies at least 3,000 unique species.

10. The method of claim 7 , wherein the analyzing step identifies at least 5,000 unique species.

11. The method of claim 7 , wherein the unique species comprises at least one of proteins or fragments thereof, lipids, or metabolites.

12. The method of claim 7 , wherein the analyzing step comprises mass spectrometry.

13. The method of claim 7 , wherein the analyzing step comprises flow cytometry.

14. The method of claim 7 , wherein the analyzing step identifies greater than 3,000 unique species from 10 or less cells.

15. The method of claim 1 , wherein the biological sample is less than 1000 nL.

16. The method of claim 1 , wherein the biological sample is less than 100 nL.

17. The method of claim 1 , wherein the platform comprises a glass chip.

18. The method of claim 17 , wherein the glass chip is pre-coated with chromium, aluminum, or gold.

19. The method of claim 17 , wherein the glass chip comprises a substrate containing the at least one reactor vessel, a spacer containing an aperture positioned on the substrate, and a cover positioned on the spacer, wherein the aperture is dimensioned to surround the at least one reactor vessel when the spacer is positioned on the substrate.

20. The method of claim 1 , wherein the introducing the capture liquid, transferring the first volume of the biological sample, processing the biological sample, and collecting the second volume of the processed sample steps are performed in a humidity-controlled chamber.

21. The method of claim 20 , wherein the humidity controlled chamber is maintained at a relative humidity within the range from about 80% to about 95%.

22. The method of claim 1 , wherein processing the biological sample comprises at least one of cell lysis, analyte extraction and solubilization, denaturation, reduction, alkylation, chemical and enzymatic reactions, concentration, and incubation.

23. The method of claim 1 , wherein the processed sample is collected into a capillary.

24. The method of claim 23 , wherein collecting the processed sample into a capillary further comprises aspirating the processed sample into the capillary and washing the single reactor vessel with a solvent.

25. The method of claim 23 , further comprising sealing the capillary from the external environment after the processed sample is collected therein.

26. The method of claim 1 , wherein the tissue comprises laser-capture microdissected tissues having dimensions less than about 1 mm.

27. The method of claim 1 , wherein the capture liquid is dimethyl sulfoxide.

28. The method of claim 1 , wherein the platform is inverted during the processing of the biological sample in the at least one single reactor vessel.

29. The method of claim 7 , wherein the biological sample comprises a complement of proteins, peptides related to the complement of proteins, or both, and the analyzing step comprises providing protein identification for each of a plurality of proteins composing the complement of proteins.

30. The method of claim 29 , wherein the tissue comprises laser-capture microdissected tissues having dimensions less than about 1 mm.

31. The method of claim 1 , wherein the capture liquid is present in an amount of at least 1 nL to 1000 nL in the at least one single reactor vessel.

32. The method of claim 1 , wherein the biological tissue is brain tissue.

33. The method of claim 29 , wherein processing the biological sample comprises at least one of cell lysis, analyte extraction and solubilization, denaturation, reduction, alkylation, chemical and enzymatic reactions, concentration, and incubation.

34. The method of claim 33 , wherein the capture liquid has a vapor pressure of less than or equal to 0.8 mbar at room temperature.

35. The method of claim 32 , wherein the capture liquid is dimethyl sulfoxide.

36. The method of claim 33 , wherein the capture liquid is dimethyl sulfoxide.

Assignees

• Battelle Memorial Institute

Inventors

• Kelly Ryan T
• Zhu Ying
• Smith Richard D

Classifications

• B01L3/5088

  confining liquids at a location by surface tension, e.g. virtual wells on plates, wires (B01L3/50857 takes precedence) · CPC title

• B01J2219/00743

  Cells · CPC title

• B01J2219/00702

  Processes involving means for analysing and characterising the products · CPC title

• B01J2219/00619

  using hydrophilic or hydrophobic regions · CPC title

• G01N33/4833

  of solid biological material, e.g. tissue samples, cell cultures (tissue in vivo A61B5/00; cell suspensions G01N33/48735) · CPC title